Science & Health
1 回表示
First patient enrolled in Phase 3 trial of tau-targeting Alzheimer’s drug
A global Phase 3 clinical trial has begun testing an experimental Alzheimer’s therapy designed to target toxic tau protein buildup, a key feature of disease progression. According to Reuters, the…
3時間前